Evidence map›Paper›PMID 32461379›Full record

ReviewAging2020

Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models.

María Álvarez-Satta, Alejandro Berna-Erro, Estefania Carrasco-Garcia, Ainhoa Alberro, Ander Saenz-Antoñanzas, Itziar Vergara, David Otaegui, Ander Matheu

Open access · hybridAbstract readReview
In one paragraph

Review in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Frailty Exacerbates Disability in Progressive Multiple Sclerosis.Annals of clinical and translational neurology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Biomarkers and Clinical Evaluation in the Detection of Frailty.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

María Álvarez-SattaGroup of Cellular Oncology, Biodonostia Health Research Institute, San Sebastian, Spain.
Alejandro Berna-ErroGroup of Cellular Oncology, Biodonostia Health Research Institute, San Sebastian, Spain.
Estefania Carrasco-GarciaGroup of Cellular Oncology, Biodonostia Health Research Institute, San Sebastian, Spain.
Ainhoa AlberroGroup of Multiple Sclerosis, Biodonostia Health Research Institute, San Sebastian, Spain.
Ander Saenz-AntoñanzasGroup of Cellular Oncology, Biodonostia Health Research Institute, San Sebastian, Spain.
Itziar VergaraGroup of Primary Health, Biodonostia Health Research Institute, San Sebastian, Spain, Health Services Research on Chronic Patients Network (REDISSEC), Spain.
David OtaeguiGroup of Multiple Sclerosis, Biodonostia Health Research Institute, San Sebastian, Spain.
Ander MatheuGroup of Cellular Oncology, Biodonostia Health Research Institute, San Sebastian, Spain.
Biogipuzkoa Health Research Institute · ESCentro de Investigación Biomédica en Red · ESSpanish Multiple Sclerosis Network · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty represents a state of vulnerability and increases the risk of negative health outcomes, which is becoming an important public health problem. Over recent years, multiple independent studies have attempted to identify biomarkers that can predict, diagnose, and monitor frailty at the biological level. Among them, several promising candidates have been associated with frailty status including antioxidants and free radicals, and also inflammatory response biomarkers. In this review, we will summarize the more recent advances in this field. Moreover, the identification of scales and measurements to detect and quantify frailty in aged mice, as well as the generation of mouse models, have started to unravel the underlying biological and molecular mechanisms of frailty. We will discuss them here with an emphasis on murine models with overexpression of glucose-6-phosphate dehydrogenase and loss of function of superoxide dismutase and interleukin 10, which reveal that altered oxidative stress and inflammation pathways are involved in the physiopathology of frailty. In summary, we provide the current available evidence, from both human cohorts and experimental animal models, that highlights oxidative damage and inflammation as relevant biomarkers and drivers of frailty.

Indexed as

Oxidative StressAgedAgingAnimalsBiomarkersDisease Models, AnimalFrailtyGlucosephosphate DehydrogenaseHumansInflammationInterleukin-10MiceSuperoxide DismutaseBiomarkersGlucosephosphate DehydrogenaseInterleukin-10Superoxide Dismutaseagingbiomarkerfrailtyinflammationoxidative stress

Identifiers

PMID32461379
PMCPMC7288972
OpenAlexW3032213372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.